This study evaluated propylene glycol monomethyl ether (PGME) in a rat 2-generation reproduction study, which included non-traditional study end points, such as sperm count and motility, developmental landmarks, estrous cyclicity, and weanling organ weights. Groups of 30 male and 30 female Sprague-Dawley rats (6-weeks-old) were exposed to 0, 300, 1000, or 3000 ppm of PGME vapors via inhalation for 6 hours/day, 5 days/week prior to mating, and 6 hours/day, 7 days/week during mating, gestation, and lactation, for 2 generations. These concentrations corresponded to estimated oral equivalent doses of 0, 396, 1325, or 3974 mg/kg/day. At 3000 ppm, toxicity in the P1 and P2 adults was marked, as evidenced by sedation during and after exposure, and mean body weights which were as much as 21% lower than controls. This marked parental toxicity was accompanied by lengthened estrous cycles, decreased fertility, decreased ovary weights, and histologic ovarian atrophy in maternal rats. In the offspring from these dams, decreased body weights, reduced survival and litter size, slight delays in puberty onset, and histologic changes in liver and thymus in the F1 and F2 offspring were observed. The nature of the reproductive/neonatal effects and their close individual animal correlation with decreased maternal body weights suggested that these effects were secondary to general toxicity and/or nutritional stress. No such reproductive/neonatal effects were observed at 1000 ppm, a concentration which caused less marked, but significant body weight effects without sedation. There were no treatment-related effects of any kind noted at 300 ppm of PGME. Therefore, the no-observable-effect level (NOEL) for reproductive/neonatal effects was 1000 ppm, and that for parental toxicity was 300 ppm.
Propylene glycol monomethyl ether (PGME) is a colorless liquid, which is miscible with water and many organic solvents. This makes it useful for a wide variety of solvent applications in the manufacture of lacquers, paints, dyes, inks, cleaning agents and liquid soaps, among others. Commercial PGME typically contains at least 97% 1-methoxy-2-propanol (␣ isomer), and only a small amount of 2-methoxy-1-propanol ( Fig. 1, ␤ isomer) . PGME has a vapor pressure of 11.8 mm Hg at 25°C, with a saturated atmospheric concentration of 5526 ppm at 25°C (calculated from the vapor pressure). PGME was assessed previously in a number of developmental and reproductive toxicity studies conducted by the oral, inhalation and subcutaneous routes of exposure (European chemical Industry Ecology and Toxicology Centre [ECETOC], 1995) . In rats, mice, and rabbits, developmental toxicity studies indicated either a lack of effects, or in some cases, minimal effects, confined mainly to minor skeletal variations (delayed ossification) only at high doses. Reproductive effects were assessed in a National Toxicology Program continuous-breeding study in which CD-1 mice were exposed to 0.5, 1.0, or 2.0% PGME in drinking water, doses which corresponded to 0.95, 1.9, and 3.3 grams/kg/day, respectively (Chapin and Sloane, 1997) . No reproductive effects were observed in that study, while effects on the F1 and/or F2 neonates were limited to decreased body weights and decreased epididymal and prostate weights seen only at the highest dose level. This profile of generally low developmental or reproductive toxicity for PGME contrasts that of ethylene glycol monomethyl ether (EGME) and ethylene glycol monoethyl ether (EGEE), which are teratogenic and cause reproductive effects, particularly testicular toxicity (reviewed in Hardin, 1983; ECETOC, 1995) . There are two critical structural features which are key determinants of glycol ether reproductive and developmental toxicity: (1) carbon chain length (inversely related to toxicity), and (2) the presence of a primary alcohol moiety. Glycol ethers, which contain primary alcohol moieties, are metabolized by alcohol dehydrogenases to their corresponding alkoxy acids (e.g., EGME 3 methoxyacetic acid; EGEE 3 ethoxyacetic acid), while those that contain secondary alcohol moieties (e.g., PGME) are poor substrates for alcohol dehydrogenases and thus, do not form appreciable quantities of alkoxy acid metabolites (Miller et al., 1983) . The alkoxy acid metabolites of EGME and EGEE have been established as the proximate developmental/reproductive toxicants for these low-molecular-weight ethylene glycol ethers (reviewed by Hardin, 1983; ECETOC, 1995) .
In order to further evaluate the potential for reproductive and neonatal toxicity of PGME, a rat 2-generation inhalation reproduction study was conducted. In addition to the standard parameters of the 2-generation test guidelines in effect at the time the study was conducted (U.S. EPA, 1985; OECD, 1983) , several newer parameters (e.g., sperm analysis, developmental landmarks, estrous cycling, weanling organ weights) were also evaluated. Exposure concentrations used in this study were selected based on two 13-week inhalation toxicity studies in rats. In the first of these, Fischer-344 rats were exposed to 0, 300, 1000, or 3000 ppm PGME for 6 h/day, 5 days/week (Landry et al., 1983) . Sedation during exposure was observed among the 3000 ppm rats for 1 to 2 weeks, as were 6 -8% increases in relative liver weights and increases in urinary pH. Histopathological observations at 3000 ppm were suggestive of adaptive hepatocellular hypertrophy without evidence of degenerative changes. In more recent 2-week, 13-week, and 2-year inhalation studies in Fischer-344 rats (Cieszlak et al., unpublished data; Corley et al., 1996) , 3000 ppm PGME, again, resulted in sedation during the first week of exposure. Resolution of sedation was temporally associated with increased relative liver weights, hepatocellular proliferation, and cytochrome P450 enzyme induction, all considered to represent a physiological adaptation of healthy tissue to the increased metabolic demand of high concentrations of PGME. In the kidneys, a dose-related increase in male rat-specific alpha 2u -globulin deposition, and a corresponding nephropathy with compensatory cell proliferation, were observed in the proximal tubules of male rats at 3000 ppm PGME. Based on these data, 3000 ppm was selected as the highest exposure concentration for the 2-generation reproduction study herein, with the expectation that this exposure level would result in readily apparent, but not excessive, parental toxicity.
MATERIALS AND METHODS
Test material. The PGME used for this study was obtained from The Dow Chemical Company (Plaquemine, LA). The test material was characterized by gas chromatography with flame ionization detection (GC/FID) and infrared spectroscopy prior to the start of the study and periodically during the course of the study. Levels of ␣ isomer (1-methoxy-2-propanol) ranged from 97.99 -98.07%, while the ␤ isomer (2-methoxy-1-propanol) assayed at 1.86 -1.90%. There were no impurities present at greater than 0.1%.
Test animals.
Male and female CD (Sprague-Dawley derived) rats (Charles River Breeding Laboratory, Kingston, NY) approximately 4 weeksof-age, were purchased for the study. Upon arrival at the laboratory, all rats were examined by a veterinarian and acclimated to the laboratory environment for approximately 2 weeks. The rats were randomly assigned by weight to the treatment groups in order to increase the probability of uniform group mean weights and standard deviations at the start of the study. The rats were identified with a uniquely coded ear tag (pups were not individually identified). In general, rats were housed singly in wire mesh, stainless-steel cages during and after inhalation exposure. The only exceptions were after exposure in late gestation and throughout lactation (pups were weaned at 21 days-of-age), when the females were housed in plastic nesting boxes with ground corn cob bedding. The animal rooms maintained relative humidity at approximately 40 -60%, temperature at approximately 22°C, photoperiod at 12-h light:12-h dark and air flow at 12-15 changes/hour. Purina Certified Rodent Chow No. 5002 (Purina Mills Inc., St. Louis, MO) was provided ad libitum except during the 6-h/day exposures, at which time feed was withheld. Drinking water was available ad libitum throughout the study, including the 6-h/day exposure intervals. Use of animals in this study was in accordance with all applicable animal welfare guidelines and regulations (USDA, CFR 91A; NRC, 1996) .
Vapor generation and exposure conditions. Whole-body inhalation exposures were conducted in 14.5 m 3 chambers under dynamic airflow conditions (approximately 2900 liters per min). The chambers were operated at a slightly negative pressure relative to the surrounding area. Control rats were placed in a chamber of identical design supplied with air without test material. Test atmospheres containing PGME were generated using the glass J-tube method of Miller et al. (1980) . Liquid PGME was metered into the glass J-tube assembly using a fluid-metering pump (Fluid Metering, Inc., Oyster Bay, NY). Compressed air (up to 100 lpm) was passed through the J-tube simultaneously to volatilize the test material. The air was heated with a heat gun (FHT-4, Master Appliance Corporation, Racine, WI) to the minimum extent necessary to facilitate complete vaporization of the test material (approximate temperatures were; 65°C for the 300 ppm chamber, 115°C for the 1000 ppm chamber, and 150 -170°C for the 3000 ppm chamber). The PGME vapors were diluted and mixed with room air to achieve the previously indicated total flow rate of approximately 2900 lpm and the desired concentration.
The concentration of PGME in the breathing zone of the animals in each chamber was measured at least once per h using a MIRAN 1A infrared spectrophotometer (Foxboro Analytical, Norwalk, CT) at a wavelength of 10.2 microns. The spectrophotometer was calibrated using standards having a known PGME vapor concentration contained in 90-liter SARAN or Tedlar film gas bags prior to the first exposure and approximately monthly thereafter. Daily checks of the spectrophotometer were performed prior to each exposure period using a single PGME standard concentration. In addition, the amount of PGME used each day was recorded and the nominal concentration (amount of PGME used/total chamber airflow) of PGME was calculated. Prior to the start of the study, each of the chambers to be used were checked to ensure that a uniform distribution of vapors occurred within the animals' breathing zone.
Airflow through each chamber was recorded hourly during the exposure with a factory calibrated Universal Venturi tube (Series 180, BIF, Providence, RI). This was coupled to a Setra Differential Pressure Transmitter (Setra System Inc., Acton, MA) and an incline manometer, which allowed for visual inspection throughout the exposures. Chamber temperatures and relative humidities were recorded hourly with a Vaisala Humidity and Resistance Temperature Device (RTD) HMD 20 YB (Vaisala, Helsinki, Finland). On one exposure day, chamber temperature, humidity, and airflow values were monitored with a thermometer and hygrometer, respectively, and airflow was monitored with the incline manometers. The Vaisala sensor in each chamber was calibrated prior to study start and approximately monthly thereafter. The temperature and relative humidity in each chamber were controlled by a system designed to maintain temperature and relative humidity at approximately 22 Ϯ 2°C and 40 -60%, respectively.
Experimental design. Groups of 30 male and 30 female rats were exposed to 0, 300, 1000, or 3000 ppm PGME via inhalation, for 6 h/day, 5 days/week for 10 weeks prior to mating, and 6 h/day, 7 days/week during mating, gestation and lactation. The atmospheric concentrations of PGME corre-
FIG. 1.
Isomeric structures of PGME.
sponded to respective oral equivalent doses of approximately 396, 1325, and 3974 mg/kg/day, assuming ventilation rates of 1 liter/min/kg and 100 percent absorption. Treatment of the first generation parental (P1) rats began at approximately 6 weeks of age. After approximately 10 weeks of exposure, P1 rats were mated (one male:one female) to produce the F1a litters. In order to confirm findings noted for the 3000 ppm F1a litters, the P1 adults were mated a second time (1 week after weaning the last F1a litter) to produce the F1b litters. Initially, 30 males and 30 females from each treatment group were randomly selected from the F1a litters and assigned to treatment groups to become the second-generation parents (P2). However, 1-3 days after exposure of the F1a weanlings commenced on postnatal day 22, it became apparent that the weanlings were too small to tolerate an absence of feed during the 6 hours of inhalation exposure. The F1a weanlings in all dose groups appeared lethargic and/or weak following exposures and did not appear interested in feed or water, even after being removed from the inhalation chambers. Therefore, exposures were temporarily discontinued for several days, until the weanlings could achieve a larger size. Exposures of these F1a weanlings resumed on postnatal day 28 and continued through to evaluation of vaginal opening and preputial separation, after which time the animals were euthanized. Due to this modification involving the F1a litter, parents for the second generation (30 males, 30 females) were randomly chosen from the F1b litters. These litters were weaned on postnatal day 21, but exposure was not initiated until postnatal day 28. After approximately 10 weeks of treatment, the P2 adults were bred to produce the F2 litters. Exposures of P1 and P2 adult rats to PGME continued until the adults were sent to necropsy. All rats were housed continuously in exposure chambers following the initial exposure to PGME, except during late gestation and throughout the lactation period, when female rats were housed outside of the exposure chambers. Maternal rats were not exposed to PGME from gestation day 20 to lactation day 4, in order to allow for parturition and initiation of lactation. During the lactation period, pups were not placed in the exposure chambers, but remained in the nesting boxes, separated from the dam, for 6 h/day on lactation days 5 through 21.
Breeding procedures. Breeding of the P1 and P2 adults commenced after approximately 10 weeks of treatment. Each female was placed with a single male from the same exposure group until pregnancy occurred or 2 weeks had elapsed. During each breeding period, daily vaginal lavage samples were evaluated for the presence of sperm, as an indication of mating. The day on which sperm were detected or a vaginal plug was observed in situ was considered day 0 of gestation. If mating did not occur during the 2 weeks, the animals were separated without further opportunity for mating. For the P2 mating, cohabitation of male and female littermates was avoided.
Parental data. All adult rats were observed daily for changes in behavior, demeanor, or overt indications of toxicity. Rats found dead or moribund were submitted for a complete pathologic examination in an effort to determine cause of death. P1 and P2 rats were weighed weekly during the pre-breeding treatment period. Following the pre-breeding period, male body weights continued to be recorded weekly. Females exhibiting evidence of mating were weighed on days 0, 7, 14, and 21 of gestation and those with litters were weighed on days 1, 4, 7, 14, and 21 of lactation. Feed consumption was not measured in this study. Estrous cycle length and normality were evaluated daily by vaginal lavage (Cooper et al., 1993) for all P1 and P2 females starting 3 weeks prior to the F1a and F2 matings only, and continued throughout cohabitation.
Litter data. All litters were examined as soon as possible after delivery. The following parameters were recorded for each litter: total litter size on the day parturition was initiated (day 0), the number of live and dead pups on days 0, 1, 4, 7, 14, and 21 postpartum, and the sex and weight of each pup on days 1, 4, 7, 14, and 21 of lactation. To reduce the variation in the growth of the pups, litters with more than eight pups were randomly culled on postpartum day 4 (4 males and 4 females per litter whenever possible). Litters with fewer than 8 pups were not culled. Any visible physical abnormalities or demeanor changes in the neonates were recorded during the lactation period. All pups found dead, or pups that were euthanized in moribund condition, were examined to the extent possible for defects and/or cause of death and preserved in neutral, phosphate-buffered 10% formalin.
Developmental landmarks. Thirty male and thirty female F1a and F1b weanlings per concentration were observed daily for vaginal opening, beginning on postnatal day 25 or male preputial separation beginning on day 35 (Korenbrot et al., 1977) . Body weights of the respective F1b rats were recorded at the time of vaginal opening or preputial separation. Triggered by effects observed on these developmental landmarks in the F1b rats, anogenital distance was measured on postnatal day 4 (after culling) for F2 male and female pups in 10 litters per exposure concentration. Vaginal opening and preputial separation were not evaluated in the F2 offspring, as the pups were sacrificed on postnatal day 22.
Gross necropsy and histopathology (adult rats). All P1 and P2 adults were given a complete gross necropsy examination. The rats were fasted overnight, anesthetized with methoxyflurane, and euthanized by decapitation. The eyes were visually examined in situ through a moistened glass slide gently pressed against the cornea. Tissue sections from all major organ systems were saved from these rats and preserved in neutral, phosphate-buffered 10% formalin or Bouin's solution (testes and epididymides). The lungs were infused with formalin to their approximate normal inspiratory volume. The nasal cavity was flushed with formalin via the pharyngeal duct to ensure rapid fixation. Weights of the ovaries or testes, left epididymis (total and cauda), seminal vesicles (with coagulating glands and their fluids), prostate, brain, liver, kidneys, lungs, adrenal glands, spleen, and thymus were determined in the first ten P1 and P2 parental animals sacrificed in each treatment group. Histologic examination of the cervix, coagulating glands, epididymides, kidneys, mammary gland, nasal tissues, ovaries, oviducts, pituitary, prostate, seminal vesicles, testes, thymus, uterus, vagina, and any gross lesions was performed on all rats in the control and high-concentration groups. Examination of tissues from the low and middle groups was limited to the liver and ovaries, as these organs demonstrated treatment-related histologic changes at the high concentration. Examined tissues were embedded in paraffin, sectioned at 6 m and stained with hematoxylin and eosin. In order to classify the severity of ovarian atrophy, a grading system was developed as follows: normal, Ͼ 25 corpora lutea; very slight, 16 -25; slight, 6 -15; and moderate, Յ 5; the severe grade was not used.
Samples of sperm from the right distal cauda epididymis from the first ten P1 and P2 males sacrificed in each exposure group were collected for evaluation of sperm motility. Sperm motility was determined with the use of the Hamilton-Thorne (HTM) Integrated Visual Optical System (IVOS) motility analyzer (Hamilton-Thorn Research, Beverly, MA). The entire left cauda epididymis was weighed and then minced in saline to enumerate the total number of sperm (cauda reserves). Sperm counts were performed manually using a hemocytometer.
Gross necropsy and histopathology (weanling rats). A complete gross necropsy on one pup/sex/exposure concentration from the first ten F1 and F2 litters was conducted on postnatal day 22. Pups were anesthetized with methoxyflurane and euthanized by decapitation. Terminal body weights were recorded. Gross examination and preservation of tissue samples were performed as described above for adults. The ovaries or testes, brain, heart, liver, kidneys, adrenal glands, spleen and thymus of these pups were weighed. The kidneys, liver, spleen, thymus, and testes were examined microscopically in the control and high concentration groups.
Statistical evaluation. Body weights, gestation/lactation body weight gains, organ weights, sperm count per gram of cauda epididymis, percent motile sperm, pup body weight (litter mean), and anogenital distance (litter mean) were first evaluated by Bartlett's test (␣, 0.01) for equality of variances (Winer, 1971) . Based upon the outcome of Bartlett's test, either a parametric (Steel and Torrie, 1960) or nonparametric (Hollander and Wolfe, 1973) analysis of variance (ANOVA) was performed (␣ ϭ 0.10). If the ANOVA was significant, a two-sided Dunnett's test, or the Wilcoxon Rank-Sum test with Bonferroni's correction (Miller, 1966) was performed (␣ ϭ 0.05). Gestation length, average time to mating, litter size, age at vaginal opening, and age at preputial separation were analyzed using a nonparametric ANOVA. If the ANOVA was significant, the Wilcoxon Rank-Sum test with Bonferroni's correction was performed. Statistical outliers were identified by the method of Grubbs (1969) , but were only excluded from analysis for documented, scientifically sound reasons. Fertility indices were analyzed by the Fisher exact probability test (␣ ϭ 0.05) and Bonferroni's correction was used for multiple testing of groups in comparison to a single control (Siegel, 1956) . Evaluation of the neonatal sex ratio was performed by the binomial distribution test (Steel and Torrie, 1960) . Survival indices and other incidence data among neonates were analyzed, using the litter as the experimental unit, by the Wilcoxon test (␣ ϭ 0.05) as modified by Haseman and Hoel (1974) . Because numerous measurements were statistically compared in the same group of animals, the overall false positive rate (Type I errors) was much greater than the cited ␣ levels would suggest. Thus, the final interpretation of numerical data considered statistical analyses along with other factors, such as dose-response relationships and whether the results were plausible in light of other biologic and pathologic findings.
Good laboratory practice. All aspects of the study were done in compliance with appropriate Good Laboratory Practice standards (OECD, 1982; U.S. EPA, 1990) .
RESULTS
Exposure data. The mean time-weighted average chamber concentrations for the 0, 300, 1000, and 3000 ppm PGME exposure groups were 0.0 Ϯ 0.00, 302.7 Ϯ 10.16, 1005.7 Ϯ 26.93, and 2996.3 Ϯ 65.47, respectively. The chamber temperatures and relative humidities were similar across exposure levels, and overall averages were within target ranges of 22 Ϯ 2°C and 40 -60% relative humidity.
Physical observations. Exposure to 3000 ppm of PGME resulted in sedation, as evidenced by incoordination and decreased activity, which was observed during the 6-hour exposure period and for various lengths of time after exposure. In all cases the sedation resolved by the next exposure day. This sedation was apparent in P1 adults during the first 3-5 weeks of exposure and in postnatal day 28 rats selected as P2 parents during the first 2 weeks of exposure. Sedation was not observed thereafter in the 3000 ppm rats nor in any rats exposed to 300 or 1000 ppm PGME at any time during the study. No other treatment-related changes in behavior or demeanor were observed in P1 adults at any exposure concentration during any phase of the study. Of the 480 adult rats on test, one control, one 300 ppm, four 1000 ppm and one 3000 ppm group rats were found dead prior to the scheduled necropsy. The causes of death of these rats were generally incidental (e.g., leukemia, peritonitis) and unrelated to treatment with PGME. No treatment-related clinical observations or physical alterations were observed for any F1a, F1b, or F2 pups from any of the exposure groups.
Body weights. Body weights of 3000 ppm P1 and P2 males and females were significantly decreased during the pre-mating, gestation, and early lactation periods relative to control body weights ( Figs. 2A-2F ). These body weight decreases were especially marked in the P2 generation, with mean body weights as much as 21% lower than controls. Among the 1000 ppm group female rats, body weights were significantly lower than controls during a limited portion of the pre-mating phase, but not during gestation or lactation. No significant effects on body weight were observed in 1000 ppm group males nor in 300 ppm group males or females at any time during the study.
Estrous cyclicity. P1 and P2 females exposed to 3000 ppm PGME exhibited an increase in the mean number of days per estrous cycle as well as a resultant decrease in the mean number of estrous cycles during the period of evaluation (Table  1) . This effect on estrous cyclicity achieved statistical significance only in the P2 females, but was considered to be biologically significant in both the P1 and P2 animals. Also, 4 out of 10 high-exposure females in each of the 2 generations exhibited atypical vaginal cytology (specific stage of cycle was difficult to ascertain). No effects on mean number of days per cycle or number of cycles per dam were noted for the 300-or 1000 ppm group dams.
Reproductive data. No treatment-related effects were observed on gestation survival index, pup sex ratios (data not shown), gestation length, or time to mating at any exposure concentration for the F1a, F1b or F2 mating/litters (Table 2) . However, decreases in F1b and F2 male and female conception and fertility indices were observed among the 3000 ppm group animals. These decreases were not always statistically identified, but were usually outside of historical control ranges and were considered treatment-related. Decreased pup survival also was noted during the lactation phase for the F1a, F1b, and F2 litters of the 3000 ppm PGME group. No treatment-related effects were observed on any index of reproduction or fertility, gestation survival (% liveborn pups), pup survival, pup sex ratios, gestation length, or time to mating at 300 or 1000 ppm PGME (Table 2) .
Decreased litter size and decreased pup body weights also were noted in the high-exposure group for the F1a, F1b and F2 litters (Table 3 ). The decreased litter sizes were reflective of significant decreases in pup survival during lactation, as mentioned above. No effects on mean litter size were observed for any of the 300 or 1000 ppm PGME group litters at any time during their respective lactation periods.
Developmental markers.
Offspring from the 3000 ppm group exhibited statistically significant delays in age at vaginal opening (F1a and F1b) and age at preputial separation (F1a only). In the females, vaginal opening was delayed by 2.6 -2.9 days, while in males, a delay of 3.1 days was observed for preputial separation (Table 4) . Both the male and female F1b rats in the 3000 ppm group weighed significantly less than controls at the time these markers of puberty were achieved. No effects on time to preputial separation or vaginal opening, or on body weight at the time of vaginal opening or preputial separation, were noted for the 300 or 1000 ppm PGME groups. No significant effects were observed on anogenital distance for F2 male or female pups at any exposure concentration tested.
Gross necropsy and histopathology (adults)
. P1 males exposed to 3000 ppm PGME exhibited statistically significant increases in relative testes, brain and kidney weights, as well as a decrease in absolute and relative thymus weight, consistent with their decreased body weights (organ weight data not shown). Among P2 males, significant increases in relative liver, lung, and seminal vesicle weights were observed. P1 females from the 3000 ppm group had significantly higher relative adrenal, liver, and lung weights, while P2 females exposed to 3000 ppm PGME had significantly decreased brain (absolute) and ovary (absolute and relative) weights relative to controls. There were no treatment-related differences in organ weights of P1 or P2 males or females exposed to 300 or 1000 ppm PGME.
No treatment-related gross pathologic changes were observed among the P1 or P2 adults at any exposure concentration. Histologically, an increased incidence of ovarian atrophy (consistent with decreased ovarian weight) was observed among the 3000 ppm PGME P1 and P2 females. Typical atrophic ovaries had fewer, or no, corpora lutea, and multiple large cystic and atretic follicles. There was no apparent increase in follicular atresia (identified by apoptotic granulosa cells) among developing follicles. Primordial and all subsequent stages in follicular maturation were evaluated qualitatively; they appeared to be present in normal numbers and were of normal appearance. The severity of ovarian atrophy was classified either as very slight, slight, or moderate (see methods). Moderate ovarian atrophy was observed in 8/30 (P1) and 10/30 (P2) females in the 3000 ppm group, as compared to a control incidence of 1/30 (P1) and 0/30 (P2). Among P2 females in the 3000 ppm group, an increased incidence of slight ovarian atrophy also occurred (4/30 vs. 0/30 for controls). However, the incidence of slight or very slight ovarian atrophy was similar among all groups in the P1 generation, probably reflecting an increased background incidence of reproductive senescence of the P1 females (8 months old) vs. the P2 females (5.6 months old). There were no treatment-related histopathological changes noted among the P1 or P2 adults exposed to 300 or 1000 ppm of PGME.
Sperm count and motility. Sperm count and motility was determined at necropsy after completion of the mating period for the adult P1 and P2 males (Table 5) . No treatment-related differences in sperm counts or motility were observed for any exposure concentration tested. A significant increase in the number of progressively motile sperm (exhibiting forward motion) obtained from P1 3000 ppm PGME males was considered spurious and not of toxicological significance.
Gross necropsy and histopathology (weanlings).
High concentration male and female weanlings generally exhibited decreased absolute weights of the kidneys, liver, spleen, testes, thymus and brain, and increased relative brain weights (data not shown). Although these changes were not always statistically identified, the trends in these organs appeared fairly consistent across the F1a, F1b and F2 litters. There were no gross lesions identified at the F1a, F1b or F2 weanling necropsy that were associated with PGME exposure. Histologically, the livers of F1a, F1b and F2 3000 ppm PGME weanlings often lacked the normal degree of glycogen vacuolation (depletion) and exhibited thymic single-cell necrosis. No significant treatment-related organ weight, gross pathological, or histopathological changes were identified among the 300 or 1000 ppm PGME weanlings.
DISCUSSION
In this 2-generation reproduction study, inhalation exposure of adult male and female Sprague-Dawley rats resulted in dose-related parental effects at 1000 (females only) and 3000 (males and females) ppm of PGME, but accompanied reproductive and neonatal effects only at 3000 ppm. Toxicity among the 3000 ppm PGME P1 and P2 animals exceeded what was anticipated, based on a 13-week inhalation study in Fischer-344 rats, which was used for dose selection (Cieszlak et al., unpublished data) . Observations of sedation during and after exposure (evidenced by incoordination and decreased activity) were made for several weeks, as opposed to only one week in the Fischer 344, 13-week study. In addition, decreases in body weights were more severe than expected with mean body weight decrements of as much as 21% relative to controls. In contrast, there were no body weight decrements noted among Fischer-344 rats exposed to concentrations of PGME as high as 3000 ppm in the 13-week study. The decreased body weights seen in the current study at 3000 ppm generally persisted throughout the pre-mating, gestation, and lactation phases of the study. Concomitant with the marked parental toxicity in the 3000 ppm group rats were reproductive effects, including lengthened estrous cycles, decreased fertility, ovarian weight decreases, and histologic ovarian atrophy. Effects on neonates also were observed at 3000 ppm PGME, and consisted of decreased body weights, decreased survival and litter size, increased time to vaginal opening or preputial separation, and histopathologic liver glycogen depletion and thymic atrophy of weanling rats. Exposure to 1000 ppm of PGME resulted in less severe, but significant, parental toxicity, expressed as decreased body weights of the P1 and P2 females during the pre-mating period. No sedation was apparent in the rats at this exposure level. In contrast to the effects observed at 3000 ppm, there were no effects on reproductive function, fertility, or neonatal growth and development. There were no effects from exposure to 300 ppm of PGME on any parameter of parental, reproductive, or neonatal toxicity.
Although this study was not intended to identify mechanisms of toxicity, the weight of evidence favors the interpretation that the aforementioned reproductive and neonatal effects at 3000 ppm were most likely secondary consequences of a (Number males siring a litter/number males which mated ) ϫ 100. b (Number females which became pregnant/number females which mated) ϫ 100. c (Number females which became pregnant/number females cohabitated with males) ϫ 100. d (Number pups alive at birth/number born) ϫ 100. e (Number pups alive on specified day/number live born) ϫ 100. * Statistically decreased relative to controls (␣ ϭ 0.05). ** Statistically decreased relative to controls (␣ ϭ 0.01).
the marked parental body-weight decrements and nutritional stress that the offspring of these animals likely experienced. Empirically, it was clear that the reproductive and neonatal effects were only observed in the presence of marked parental toxicity, and did not occur at lower exposure levels associated with slight (1000 ppm) or no (300 ppm) parental toxicity. Also, there appeared to be a close correlation on an individual animal basis between the magnitude of body-weight decrement and the incidence of most effects. For example, in the P2 generation, where there was a clear increase in the incidence of ovarian atrophy uncomplicated by age-related senescence (as in the P1 females), the subset of females exhibiting ovarian atrophy had mean pre-mating body weights which were 20 -24% lower than controls. In contrast, the body weights of unaffected 3000 ppm group females were only 10 -18% lower than controls. In addition, of the 14 high-exposure P2 females that failed to become pregnant, only one did not exhibit histologic ovarian atrophy at study end. Thus, there was a high individual correlation between decreased pre-mating body weights, effects on estrous cyclicity, failure to achieve pregnancy, and ovarian atrophy. The qualititative nature of the reproductive and neonatal toxicity seen at 3000 ppm also suggests that these effects were secondary to parental toxicity and nutritional stress in the offspring. For one, the effects seen were not at all characteristic of the toxicity caused by certain glycol ethers (e.g., ethylene glycol monomethyl ether), predominantly manifested as testicular atrophy, altered sperm morphology, and decreased male fertility (reviewed in Hardin, 1983; ECETOC, 1995; Morrissey et al., 1989 ). In the current study with PGME, there were no effects on testicular or epididymal histopathology, sperm counts, sperm motility, sperm morphology, or any other malespecific parameter. Instead, the female appeared to be the affected sex in this study, with the predominant changes involving the ovary (ovarian atrophy, decreased ovary weights, and increased estrous cycle length). It is well known that marked body weight decrement can lead to ovarian dysfunction, even in the absence of chemical exposure. Rats subjected to graded degrees of feed (caloric) restriction during adulthood exhibited increased estrous cycle lengths when body weights were decreased by 30% vs. ad lib-fed controls (Chapin et al., 1993; Keenan et al., 1996) . In a recent study conducted in our laboratory, body weight decreases of a similar magnitude, caused by feed restriction during in utero, neonatal, and adolescent life, also resulted in lengthened estrous cycles (Carney et al., 1998 ). In the current study with PGME, mean female body weights of the 3000 ppm group were decreased by as much as 21%, and the subset with ovarian atrophy decreased by an average of 24%, putting these animals close to the level of feed restriction associated with ovarian effects. In addition, the animals in the current study with PGME had a further stress due to lack of access to feed for 6 h/day during inhalation exposure, which was extended, in the 3000 ppm rats, by a further period of significant post-exposure sedation. A resultant alteration of feeding pattern may have compounded the reproductive effects seen in this study, based on data showing that restricting feed access for Յ8 h/day can inhibit estrous cyclicity, decrease ovarian weights, and generally inhibit ovarian function (Parshad, 1990) . In a similar manner, the findings among the 3000 ppm F1a, F1b and F2 offspring, specifically decreased pup body weights and survival, weanling organ weight changes, thymic and liver histopathological alterations, and delayed vaginal opening and preputial separation, are all effects that are highly body-weight dependent. In our recent study of feed restriction of dams during gestation and lactation (Carney et al., 1998) , maternal body weight decreases of only 10 -20% relative to controls resulted in significantly decreased pup body weights. Slightly higher degrees of maternal restriction also affected pup survival and caused a delay of 6 days in the age at vaginal opening and preputial separation. The decreases in absolute weights of the kidneys, liver, spleen, testes, thymus, and brain observed among the 3000 ppm group weanlings were also seen with moderate maternal feed restriction, as were increased relative brain weights. These increased relative brain weight changes were consistent with the known brain-sparing strategy of the fetus and neonate in the face of nutritional stress. The histopathological findings of thymic single cell necrosis and liver glycogen depletion are typical of caloric restrictions that cause substantial body weight decrements (Feron et al., 1973) . In assessing the potential reproductive hazards associated with exposure to PGME vapors, it is equally important to focus on the fact that reproductive or neonatal effects were not observed in rats exposed to 1000 ppm, despite the presence of significant, although less severe, parental toxicity among the P1 and P2 females. This finding is consistent with the results of a National Toxicology Program continuous-breeding study, in which mice were exposed to 0.5, 1.0, or 2.0% PGME in their drinking water, followed by assessment of fertility, pup survival, pup body weights, and sperm parameters (Chapin and Sloane, 1997) . Despite the high concentrations tested in the continuous breeding study (0.95, 1.89, and 3.33 grams/kg body weight, respectively), and the high sensitivity of this test protocol, there were no effects of PGME on fertility, litter size, or sperm parameters. Treatment-related effects confined to the high dose consisted only of decreases in pup body weights.
In conclusion, inhalation exposure of male and female Sprague-Dawley rats for two generations resulted in reproductive and neonatal effects at 3000 ppm, while no reproductive or neonatal effects were seen at 1000 or 300 ppm. The reproductive effects appeared to affect only the female, and consisted mainly of lengthened estrous cycles, ovarian histological changes, and reduced fertility. The neonatal effects primarily involved decreased body weights, reduced survival and litter size, slight delays in puberty onset, histologic liver glycogen depletion, and thymic single-cell necrosis. These reproductive and neonatal effects occurred only at maximal concentrations (estimated oral equivalent dose of almost 4000 mg/kg/day), and were most likely secondary to the markedly decreased parental body weights and sedation noted at this concentration. The no-observed-effect-level (NOEL) for fertility and reproductive effects in this two-generation inhalation reproduction study was 1000 ppm PGME, while the NOEL for parental toxicity was 300 ppm.
